{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-063755","form_type":"8-K","ticker":"CBUS","cik":"0001705843","company_name":"Cibus, Inc.","filed_at":"2024-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.183423+00:00","generated_at":"2026-06-05T00:37:03.894839+00:00","sec_items":["2.02","2.06","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cibus estimates $249.4M non-cash impairment charge on goodwill and IPR&D","bullets":["Goodwill impairment of $150.4M and in-process R&D impairment of $99.0M for fiscal 2023.","Total non-cash impairment charge of ~$249.4M, related to assets from Cibus Global merger.","Triggered by qualitative factors including stock price decline, macro conditions, and development progress.","Preliminary and unaudited; subject to change upon completion of 10-K and audit by BDO USA.","Company expects no current or future cash expenditures from the impairments."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-063755","json":"https://secwatch.observer/filing/0001193125-24-063755.json","markdown":"https://secwatch.observer/filing/0001193125-24-063755.md","text":"https://secwatch.observer/filing/0001193125-24-063755.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1705843/000119312524063755/0001193125-24-063755-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1705843/000119312524063755/d808151d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T00:37:03.894839+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9cbaf92361ce7429f303fd453ff5b56e87b1c75d","claim":"Cibus, Inc. announced a impairment with charges of an estimated approximately $249.4 million affecting goodwill and in-process R&D indefinite-lived intangible assets acquired in the merger transactions with Cibus Global, LLC.","evidence_excerpt":"management expects to record a non-cash impairment charge of an estimated approximately $249.4 million for impairment of goodwill and in-process R&D indefinite-lived intangible assets in the consolidated financial statements for the year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1705843/000119312524063755/0001193125-24-063755-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"impairment"},{"label":"Charge","value":"an estimated approximately $249.4 million"},{"label":"Affected area","value":"goodwill and in-process R&D indefinite-lived intangible assets acquired in the merger transactions with Cibus Global, LLC"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}